Literature for peptidase S01.134: myeloblastin

(References are filtered for relevance to Target. To remove the filter click here. See explanation.)

2016
1. Korkmaz,B., Lesner,A., Guarino,C., Wysocka,M., Kellenberger,C., Watier,H., Specks,U., Gauthier,F. and Jenne,D.E.
   Inhibitors and antibody fragments as potential anti-inflammatory therapeutics targeting neutrophil proteinase 3 in human disease
   Pharmacol Rev68, 603-630. PubMed  Europe PubMed DOI  V  T
2012
2. Wiedl,T., Collaud,S., Hillinger,S., Arni,S., Burgess,C., Kroll,W., Schraml,P., Soltermann,A., Moch,H. and Weder,W.
   KRAS Mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma
   Cancer Genomics Proteomics9, 51-54. PubMed  Europe PubMed  T
2010
3. Korkmaz,B., Horwitz,M.S., Jenne,D.E. and Gauthier,F.
   Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases
   Pharmacol Rev62, 726-759. PubMed  Europe PubMed DOI  V  T